Kyntra Bio, Inc. (KYNB) — Capital Reinvestment Ratio
Kyntra Bio, Inc. (KYNB) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.68 Million) in capital expenditures ($13.00K). See free cash flow generation of Kyntra Bio, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kyntra Bio, Inc. Capital Reinvestment Ratio (2013–2020)
This chart tracks Kyntra Bio, Inc.'s Capital Reinvestment Ratio across 4 annual periods. See Kyntra Bio, Inc. (KYNB) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Capital Reinvestment Ratio for Kyntra Bio, Inc. (2013–2020)
Year-by-year Capital Reinvestment Ratio for Kyntra Bio, Inc. from 2013 to 2020. For the full cash flow conversion analysis, see Kyntra Bio, Inc. (KYNB) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $81.60 Million | $3.99 Million | ▼ -72.2% |
| 2016 | 0.18x | $7.11 Million | $1.25 Million | ▼ -51.4% |
| 2014 | 0.36x | $22.41 Million | $8.12 Million | ▲ +37.9% |
| 2013 | 0.26x | $25.92 Million | $6.81 Million | — |